Cytek Biosciences (CTKB) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cytek Biosciences (CTKB) has outperformed Quanterix (QTRX) over the past year, gaining 40.9% versus a loss of 41.3%. Over five years, CTKB leads with a -77.8% price change compared with -93.6% for QTRX. Cytek Biosciences is the larger company by market cap ($694.1 million vs $157.2 million), about 4.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTKB | QTRX |
|---|---|---|
| Share price | $5.34 | $3.33 |
| Market cap | $694.11M | $157.25M |
| 1-day change | -0.74% | -3.34% |
| YTD return | +5.74% | -47.72% |
| 1-year return | +40.90% | -41.25% |
| 5-year return | -77.81% | -93.57% |
| Forward P/E | 76.29 | — |
| EPS (TTM) | $-0.62 | $-2.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.21 | $8.77 |
| 52-week low | $3.31 | $2.15 |
| Distance from 52-week high | -14.01% | -62.09% |
| Analyst consensus | none | none |
| Avg. price target upside | +4.12% | -9.77% |
| Average volume | 1.03M | 761.20K |
| Shares outstanding | 129.98M | 47.29M |
| Employees | 682 | 450 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cytek Biosciences is about 4.4 times larger than Quanterix by market value ($694.11M vs $157.25M).
- CTKB has outperformed QTRX by 82.2 percentage points over the past year.
About Cytek Biosciences
CTKB stock →Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.
Healthcare · Medical Devices · 682 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Healthcare · Medical Devices · 450 employees
CTKB vs QTRX FAQ
Which is bigger, Cytek Biosciences or Quanterix?
Cytek Biosciences (CTKB) is larger, with a market capitalization of $694.11M compared with $157.25M for Quanterix (QTRX).
Which stock has performed better over the past year, CTKB or QTRX?
CTKB returned +40.90% over the past 12 months, compared with -41.25% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Cytek Biosciences and Quanterix in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.